Antitubercular Agents Concept

subject area of

• <I>CYP7A1</I>, <I>BAAT</I> and <I>UGT1A1</I> polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity  Academic Article
• 1,4-Dihydropyridine Scaffold in Medicinal Chemistry, The Story So Far And Perspectives (Part 2): Action in Other Targets and Antitargets  Academic Article
• CYP2E1,GSTM1andGSTT1genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study  Academic Article
• A knowledge translation intervention to improve tuberculosis care and outcomes in Malawi: a pragmatic cluster randomized controlled trial  Academic Article
• A standardised method for interpreting the association between mutations and phenotypic drug resistance inMycobacterium tuberculosis  Academic Article
• Acute renal failure and disseminated intravascular coagulation associated with rifampin in tuberculosis treatment  Academic Article
• Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial  Academic Article
• Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis  Academic Article
• Adverse Reactions Due to Directly Observed Treatment Strategy Therapy in Chinese Tuberculosis Patients: A Prospective Study  Academic Article
• Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis.  Academic Article
• Analysis of IL-6, STAT3 and HSPA1L Gene Polymorphisms in Anti-Tuberculosis Drug-Induced Hepatitis in a Nested Case-Control Study  Academic Article
• Apocalypse or redemption: responding to extensively drug-resistant tuberculosis  Academic Article
• Association of polymorphisms in drug transporter genes (SLCO1B1 and SLC10A1) and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort  Academic Article
• Atypical presentation of spinal tuberculosis.  Academic Article
• Back to the future: a new ‘old’ lead for tuberculosis  Academic Article
• Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis  Academic Article
• Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform: Figure 1.  Academic Article
• Cryptococcosis and tuberculosis co-infection in mainland China  Academic Article
• Cytochrome P450 2E1 Gene Polymorphisms/Haplotypes and Anti-Tuberculosis Drug-Induced Hepatitis in a Chinese Cohort  Academic Article
• Decline of antibiotic use in primary care – Authors' reply  Academic Article
• Diagnosis of drug-resistant TB and provision of second-line TB treatment in India: some ethical considerations  Academic Article
• Does treatment collection and observation each day keep the patient away? An analysis of the determinants of adherence among patients with Tuberculosis in South Africa  Academic Article
• Drug-resistant tuberculosis: an insurmountable epidemic?  Academic Article
• Effect of antitubercular medications on blood pressure control in chronic kidney disease patients with tuberculosis: a prospective cohort study.  Academic Article
• Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China  Academic Article
• Evaluation of a tuberculosis screening program for high-risk students in Toronto schools.  Academic Article
• HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis  Academic Article
• Inaccuracy of Death Certificate Diagnosis of Tuberculosis and Potential Underdiagnosis of TB in a Region of High HIV Prevalence  Academic Article
• Interleukin-4 and interleukin-10 polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese population  Academic Article
• Interventions for treating tuberculous pericarditis  Academic Article
• Isoniazid for preventing tuberculosis in non-HIV infected persons  Academic Article
• Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials  Academic Article
• Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity  Academic Article
• Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries  Academic Article
• Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC  Academic Article
• Miliary tuberculomas of the brain: case report  Academic Article
• Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future  Academic Article
• NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population  Academic Article
• Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis  Academic Article
• Predictors of In-Hospital Mortality among Patients with Pulmonary Tuberculosis: A Systematic Review and Meta-analysis  Academic Article
• Predictors of survival and eradication of Mycobacterium avium complex bacteremia (MAC) in AIDS patients in the Canadian Randomized MAC Treatment Trial  Academic Article
• Preventive use of hepatoprotectors yields limited efficacy on the liver toxicity of anti-tuberculosis agents in a large cohort of Chinese patients  Academic Article
• Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients’ treatment adherence via electronic monitors and an app versus usual care in Tibet  Academic Article
• Radiological findings of isolated hepatic tuberculosis in a child with tubulointerstitial nephritis-uveitis syndrome  Academic Article
• Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: A 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis  Academic Article
• Reciprocity and Ethical Tuberculosis Treatment and Control  Academic Article
• Repair of Tuberculous Aneurysm of Distal Aortic Arch  Academic Article
• Role of pharmaceutical care for self-administered pulmonary tuberculosis treatment in Thailand  Academic Article
• Role of polymorphic bile salt export pump (BSEP, ABCB11) transporters in anti-tuberculosis drug-induced liver injury in a Chinese cohort  Academic Article
• Serum soluble interleukin-2 receptor: A useful indicator of the clinical course in pulmonary tuberculosis  Academic Article
• Single-Dose Mucosal Immunotherapy With Chimpanzee Adenovirus-Based Vaccine Accelerates Tuberculosis Disease Control and Limits Its Rebound After Antibiotic Cessation  Academic Article
• The association between HLA-DQB1 polymorphism and antituberculosis drug-induced liver injury: a Case-Control Study  Academic Article
• The effect of weekly text-message communication on treatment completion among patients with latent tuberculosis infection: study protocol for a randomised controlled trial (WelTel LTBI)  Academic Article
• Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis  Academic Article
• Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline  Academic Article
• Tuberculosis Prevention and Control in Long-Term–Care Facilities for Older Adults  Academic Article
• Tuberculosis in Somalia  Academic Article
• Tuberculosis in patients with human immunodeficiency virus infection.  Academic Article
• Use of Anti-Retroviral Therapy in Tuberculosis Patients on Second-Line Anti-TB Regimens: A Systematic Review  Academic Article
• WHO guidance on multidrug-resistant tuberculosis treatment: using and communicating the evidence  Academic Article
• WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update  Academic Article
• World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update  Academic Article
• [Study on polymorphisms of genes with susceptibility to drug induced liver injury in a cohort receiving anti-tuberculosis treatment].  Academic Article